Last reviewed · How we verify
Diluted Humalog U-200 Insulin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Diluted Humalog U-200 Insulin (Diluted Humalog U-200 Insulin) — Stanford University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Diluted Humalog U-200 Insulin TARGET | Diluted Humalog U-200 Insulin | Stanford University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Diluted Humalog U-200 Insulin CI watch — RSS
- Diluted Humalog U-200 Insulin CI watch — Atom
- Diluted Humalog U-200 Insulin CI watch — JSON
- Diluted Humalog U-200 Insulin alone — RSS
Cite this brief
Drug Landscape (2026). Diluted Humalog U-200 Insulin — Competitive Intelligence Brief. https://druglandscape.com/ci/diluted-humalog-u-200-insulin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab